Introduction. Women with endometriosis often experience pain and infertility. Medical treatment interferes with the possibility of attaining pregnancy. For infertile women with endometriosis, surgery is a possible treatment, but with advanced disease there is an increased risk of serious complications. With only limited pain, women will often be referred for in vitro fertilization treatment instead. The disease is estrogen-dependent and during in vitro fertilization treatment the women could theoretically experience worsening of their symptoms. Material and methods. The study is a retrospective cohort study of 76 women with bowel endometriosis who were treated conservatively and underwent in vitro fertilization treatment. Results. Nine (11.8%) of the women experienced severe worsening of their bowel-related symptoms, including two patients presenting with colon ileus. One additional woman had no previous diagnosis of endometriosis before she presented with subocclusion of the bowel during in vitro fertilization. In all cases the in vitro fertilization treatment was stopped. Conclusions. Our study revealed that bowel endometriosis increases the risk of complications during in vitro fertilization treatment. This is in contrast to several publications. However, our study population is different due to the fact that none of these women had previous operations for bowel endometriosis. In all, 88% of the women completed fertility treatment without need for surgery.
Introduction
Endometriosis is defined by ectopic occurrence of endometrium-like tissue causing local inflammation with subsequent pain and infertility (1, 2) . The disease is estrogendependent and medical therapies include oral contraceptives, progestogen monotherapy and gonadotropin analogue releasing hormone (GnRH) downregulation (3) . These drugs can generally not be used when patients want to become pregnant, and surgery is the option when treatment is needed in this situation.
The predominant indication for surgery is pain. Radical removal of endometriotic tissue with preserved fertility is attempted and the approach depends on the phenotype of endometriosis. This includes peritoneal disease, where surgery improves the spontaneous pregnancy rate (4) and possibly also in vitro fertilization (IVF) outcome (5) . Endometrioma surgery may reduce ovarian follicle reserve, indicating a conservative approach in infertility patients (6) . However, there are also data showing increased fertility rate after surgery for endometrioma (7) .
Key Message
Women with bowel endometriosis risk aggravation of bowel symptoms during IVF treatment for infertility. Deep infiltrating endometriosis (DIE) is the most severe form with invasive growth, typically in the rectovaginal septum with frequent involvement of the vagina and bowel wall (8) . Surgery for bowel DIE is complex with risk of complications (9) , and patients with sparse or no symptoms and those responding to medical treatment may therefore be treated conservatively (10) . In a few of these women, stenosis of the bowel (11) or ureter (12) may develop, with compelling need for intervention.
In vitro fertilization is often indicated when women with endometriosis want to become pregnant. This involves controlled ovarian stimulation, which might induce progression of DIE (13) . In accordance, early reports indicated that IVF in DIE patients can result in bowel or ureter stenosis (14) (15) (16) , although the precise mechanism is unknown. Subsequent prospective studies have not provided evidence of symptomatic progression during IVF treatment (17) (18) (19) (20) , but this discrepancy could reflect less advanced disease in the study populations.
Some years ago, one of our conservatively treated women experienced a colon occlusion because of a large nodule of bowel endometriosis during IVF treatment. Since this is a serious complication, potentially leading to major and/or even acute surgery, we found that further evaluation of risk of bowel obstruction in women with conservative treatment of endometriosis during fertility treatment was important. The aim of this study was therefore to investigate the probability of bowel obstruction in women with bowel DIE during fertility treatment.
Material and methods
Our department represents one of two Danish referral centers for endometriosis and receives patients with suspected or diagnosed DIE from the western part of Denmark (background population approximately 2.5 million).
The diagnosis is based on anamnestic history, clinical examination including transvaginal ultrasound and in the majority of cases also magnetic resonance imaging (MRI). Our department has a significant experience in transvaginal ultrasound in the diagnosis of bowel endometriosis, as described previously (21) . The primary strategy is to treat the women conservatively, i.e. with medication including oral contraceptives, progestogens or levonorgestrel-containing intrauterine devices when the woman does not have a present fertility wish. The women are seen for clinical control every year for possible adjustment of the treatment. There is no systematic registration of visual analogy scale score regarding pain intensity; however, all clinical controls are performed by experienced specialists from the endometriosis team. In the case of worsening in symptoms, the women can contact the center for additional control.
Surgery is performed when medical treatment has failed, in case of bowel or ureter stenosis and in infertility patients with unacceptable pain. In some cases the patients themselves want an operation despite our conservative approach.
We performed an audit of 179 consecutive women with bowel DIE treated conservatively from 2007 to 2013, representing 51% of cases referred to our center with bowel involvement in the study period. The remaining 49% all had bowel resection performed (22) . The diagnosis was based on clinical examination combined with transvaginal ultrasound and/or MRI. More than 85% had an MRI scan performed, the remaining transvaginal ultrasound only. Data collected included demographic information, date of birth, weight and height, previous operations for endometriosis (number), oophorectomy status, current medical treatment (at the time of audit), and results of MRI findings with respect to location(s) of endometriosis. This cohort has been described in detail previously (22) .
Among the women primarily treated conservatively, a subgroup had fertility treatment in the following 2 years. We identified the women with IVF-related significant worsening of pain and/or severe bowel stenosis leading to operation. For these women also, patient files from other hospitals including fertility clinics were reviewed. Regarding fertility treatment, all cycles were initiated with GnRH downregulation at day 21 in the previous cycle. Treatment was according to the Danish guideline for IVF treatment.
Ethical approval
This study was registered and approved by the Danish Data Protection Agency, 12 June 2013, J.nr. 2013-41-2033. Written consent was obtained from the women.
Results
Out of 179 patients treated conservatively for DIE with bowel affection, 76 underwent IVF treatment during the study period. Nine of these women (11.8%) experienced severe worsening of their bowel symptoms and were seen for additional control in our center. In addition, one woman without previous diagnosis of DIE was referred to us with severe pain and had DIE with bowel involvement diagnosed. This woman was a patient in our fertility clinic, but was not diagnosed with endometriosis before initiation of fertility treatment despite the fact that she had dyschezia, dyspareunia and dysmenorrhea. MRI or transvaginal ultrasound for bowel involvement was not included at the examination at the fertility clinic.
The average age was 33 years and average body mass index was 24.2 (3.4) kg/m 2 . The protocol for fertility treatment was according to the Danish national guideline. This consists of 3 months of GnRH-agonist treatment with subsequent stimulation initiated 2 weeks after the last GnRH-agonist injection. The women received between 1087 and 5700 IE follicle-stimulating hormone per IVF cycle and had on average three IVF attempts (range two to seven). Table 1 shows details of all 10 women. Nine of the women had their bowel endometriosis diagnosed before IVF treatment. Seven of them had an MRI performed before IVF, the remaining three had the MRI performed before operation. The bowel nodules were all located in the rectum with only two located in the low rectum (<5 cm from the anal verge). In four women we found two bowel nodules during surgery.
Two of the women presented with occlusion of the colon. One of these had ileostomy performed, whereas the other was treated with decompression through colonoscopy. Six women had sub-occlusion and were treated conservatively including increased treatment with laxatives and GnRH downregulation (i.e. 3 months of GnRH downregulation with add-back therapy consisting of lowdose estrogen/progestogen) until operation. In these cases the women's symptoms included severely increased pain, dyschezia, paradoxical diarrhea and bloating. Some of the women had symptoms of stenosis of the bowel leading to toilet visits during the night. The last two women only had severe worsening of their pain symptoms without signs of severe stenosis.
All 10 women had a successive bowel resection performed before continued fertility treatment. Following surgery, five women became pregnant after eventless IVF treatment, one became pregnant spontaneously, three did not become pregnant despite IVF treatment and one woman chose adoption instead of IVF.
Discussion
Our results show that women treated medically for DIE with bowel involvement experience a significant risk of worsened symptoms when their treatment is replaced by controlled ovarian stimulation before IVF. This risk amounted to almost 12% in our population of 76 IVF patients with well-defined disease. Subocclusion/occlusion of the bowel was the predominant problem at admission.
Interpretation of our results is impeded by the retrospective design, and a prospective study would have offered more specific data, for example concerning details of the IVF treatment that might predispose to pain recurrence and also registration of visual analogy scale scores. Strengths of the study include the large cohort with detailed diagnosis. With these considerations in mind, our data allow for comparison with existing data in the field. Previous studies have shown diverging results on the risk of pain recurrence when women with DIE undergo IVF treatment. Santulli et al. (18) reported detailed data on 102 endometriosis patients where 46% had DIE with bowel involvement. No worsening of symptoms was observed during or after IVF, but no information was given on the principles for conservative treatment. There was no data on how many of the women had an operation performed removing the bowel endometriosis. It is therefore possible that the endometriosis centers involved before IVF had a more active surgical approach compared with our principles, thereby having a larger proportion of patients undergoing primary surgery. This could reduce the potential for worsened symptoms during ovarian stimulation.
Benaglia et al. also failed to detect any significant pain recurrence during IVF (17) , but this series comprised only nine women with DIE, and the number of patients with bowel involvement and the criteria for conservative treatment were not specified. In addition, the nodules were quite small in size (average 10 mm).
Taken together, the divergence between these previous findings and our study might reflect differences in patient population. Hence, our conservative attitude toward bowel DIE may imply fewer overall major surgical complications, but a higher risk for significant pain development and need for surgery during IVF treatment.
Our series included only patients referred for specialized treatment, and we have no data on the remaining 66 women who completed IVF treatment without being referred back to us due to worsening of symptoms. It is therefore possible that a larger number of women have experienced significant pain. A prospective study is currently being performed at our unit to evaluate this aspect.
Unfortunately, our data do not allow us to speculate regarding the mechanism leading to the growth of the bowel nodules. The influence of increased estrogen level during stimulation is obvious; however, the majority of patients in our cohort did not experience severe worsening. In theory some of the women might have increased sensitivity to estrogen due to more active endometriosis. Ovarian hyperstimulation syndrome is known as a cause of discomfort and pain. However, occlusion or subocclusion of the rectum has, to our knowledge, not been described with ovarian hyperstimulation syndrome. None of the women in this study had large ovaries or increased intraperitoneal fluid when they were seen in our clinic -and therefore did not have ovarian hyperstimulation syndrome.
Seven of the women in this study have had a previous diagnostic laparoscopy showing frozen pelvis with severe adhesions between the bowel and the uterus. These women were all referred directly to a fertility clinic. In five of the women, an MRI was performed by the IVF clinic after the referral. We suggest that the discovery of frozen pelvis requires a more thorough diagnostic evaluation, possibly at a referral center for advanced endometriosis. One of the women had no diagnostic laparoscopy but was described with severe symptoms of advanced endometriosis. Also in such a case, a referral for diagnosis could be justified.
In agreement with our findings, Roman et al. reported data on 12 young women with conservatively treated bowel DIE and wish for pregnancy where bowel subocclusion/occlusion developed -in three of these cases during IVF treatment (23) . These 12 patients corresponded to 5% of the 241 women managed for bowel endometriosis in their center. This indicates a significant risk of worsened symptoms when patients with untreated bowel DIE try to conceive.
Both medical and surgical preventive measures can be proposed to avoid problems when patients with bowel DIE undergo IVF treatment. GnRH pretreatment improves IVF outcomes (24) and would cause at least transient atrophy of DIE (25) , but it is not known whether this is sufficient to prevent or dampen the worsening of symptoms in bowel DIE. The length of this potential effect in case of repeated IVF is also unclear. However, all women in this study had GnRH pretreatment.
Primary surgery before start of IVF is another possibility to avoid worsened bowel symptoms. The presence of DIE is a determinant for poor IVF outcome (25) and some data (26) (27) (28) (29) suggest that patients with bowel endometriosis benefit from surgical excision before IVF.
Further evidence is needed on this aspect and any anticipated positive effects should be weighed against the risk of complications to bowel surgery (30) .
Everything considered, our data show that the risk of aggravated symptoms must be taken into account when patients with bowel DIE undergo IVF, and probably a significant number will present with need for intervention. Still 88% of the patients completed fertility treatment without compelling need for surgery. Suspicion of endometriosis by the anamnestic history or by finding of frozen pelvis at laparoscopy should lead to further diagnostic evaluation, or at least to thorough information for women about the signs of bowel occlusion before IVF treatment.
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